Robot model
Indego
Parker Hannifin's Indego is a powered lower-limb exoskeleton, FDA-cleared via 510(k) in 2016, intended to enable individuals with spinal cord injury at levels…
- Manufacturer
- Parker Hannifin Indego
- Form factor
- exoskeleton
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 3
Indego holds 1 FDA 510(k) clearance, per the DEPLOY registry.
See all 1 filingsOverview
Parker Hannifin's Indego is a powered lower-limb exoskeleton, FDA-cleared via 510(k) in 2016, intended to enable individuals with spinal cord injury at levels T7 to L5 to perform ambulatory functions with supervision of a specially trained companion.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Sources on file
- View all sources →
Key facts
Form factor
Clearance
Indication
Specs
Class
Clearance
Indication
Data & sources
Web sources
1
1 source backing this record.View all →
Pricing
No verified price is on record for Indego. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Deployments (3)
- Indego at Nashvilleoperational
Vanderbilt Medical Center participated in 4-year DOD-funded multi-center study.
- Indego at West Orange, New Jersey, USAoperational
Kessler Foundation designated as study site for Indego multi-center research.
- Indego at Atlantaoperational
Shepherd Center in Atlanta served as Parker's lead clinical partner for Indego testing and training.
Indego on the deployment map
View the global mapWhere Indego is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 24, 2026
Added to the verified registry
- Deployment verifiedVerifiedOct 22, 2015
at Nashville
- Deployment verifiedVerifiedOct 15, 2014
at West Orange, New Jersey, USA
- Deployment verifiedVerifiedSep 1, 2014
at Atlanta
Regulatory filings (1)
- fda_510kfda 510k · us_fdacleared2016-01-01
Applicant: Ekso Bionics
Safety record
No incidents on record for Indego.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (1)
Mentioned on (4)
Registry pages whose text names Indego.
Companies (1)
People (3)
Common questions
What is Indego?
How much does Indego cost?
Is Indego actually deployed in the real world?
Who makes Indego?
Where is Indego deployed?
Can you buy Indego?
Is Indego FDA cleared?
What are alternatives to Indego?
How does Indego compare to Ant-H1 Pro?
Is Indego a top exoskeleton?
What is Indego's maturity stage?
Is Indego safe?
What is the Parker Indego exoskeleton?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-10-10
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-10-10
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: exoskeleton
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Indego.Recent coverage
Indego in third-party press
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning Indego from third-party publications. Automatically surfaced; not part of the verified registry record.
Ekso Bionics acquires Human Motion and Control Business Unit, Indego product line from Parker Hannifin Corp.
Ekso Bionics buys Indego lower limb exoskeleton business from Parker Hannifin for $10M
Ekso Bionics buys Indego exoskeletons from Parker Hannifin
Comparing Indego vs Ekso GT vs ReWalk, Researched by VAPAHCS
Indego joins Ekso with FDA exoskeleton approvals
You Can Now Buy This Robotic Exoskeleton to Help You Walk
Indego Cleared By FDA For Clinical And Personal Use
Parker Hannifin’s Robotic Exoskeleton Gets FDA OK for Personal Use
FDA approves Vanderbilt-designed Indego exoskeleton for clinical and personal use
Machine-readable surfaces
- Markdown mirror: /models/parker-indego.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/894204d2-44c2-4f9e-9261-5d64481f866a
- Revision history: /models/parker-indego/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
Indego draws attention at the 56th percentile but verifies reality at the 80th percentile among exoskeletons. Hype Gap -24, 28th widest among exoskeletons.
6-month trend
Analysis
Limited independent press and video coverage to date.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Nov 20, 2026